Gw Pharma ADR (GWPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | 09-2018 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 486,752 | 536,933 | 591,497 | 354,913 | 322,154 |
| Receivables | 71,168 | 48,883 | 4,192 | 2,122 | 1,367 |
| Inventories | 129,138 | 85,528 | 33,030 | 19,061 | 5,669 |
| TOTAL | $729,530 | $699,636 | $646,622 | $390,711 | $364,582 |
| Non-Current Assets | |||||
| PPE Net | 143,767 | 127,765 | 90,832 | 82,381 | 63,175 |
| Intangibles | 12,524 | 6,959 | 6,959 | 6,959 | 6,959 |
| Other Non-Current Assets | 53,690 | 47,889 | 11,655 | 10,484 | 8,206 |
| TOTAL | $209,981 | $182,613 | $109,446 | $99,824 | $78,340 |
| Total Assets | $939,511 | $882,249 | $756,068 | $490,535 | $442,922 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 21,870 | 9,990 | 9,796 | 9,741 | 7,757 |
| Accrued Expenses | 127,849 | 99,374 | 52,477 | 46,739 | 33,656 |
| Other current liabilities | 9,210 | 7,760 | 1,559 | 804 | 2,377 |
| TOTAL | $159,806 | $117,561 | $66,216 | $58,669 | $44,909 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 4,378 | 4,611 |
| Other Non-Current Liabilities | 33,161 | 33,081 | 10,082 | 10,794 | 10,838 |
| TOTAL | $38,615 | $38,654 | $15,772 | $16,707 | $17,190 |
| Total Liabilities | $198,421 | $156,215 | $81,988 | $75,376 | $62,099 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 31,349 | 30,978 | N/A | N/A | 25,370 |
| Common Shares | 577 | 570 | 564 | 530 | 482 |
| Retained earnings | -896,087 | -837,959 | -828,940 | -757,034 | -461,867 |
| Other shareholders' equity | -53,551 | -68,623 | -78,688 | -75,194 | -74,518 |
| TOTAL | $741,090 | $726,034 | $674,080 | $415,159 | $380,823 |
| Total Liabilities And Equity | $939,511 | $882,249 | $756,068 | $490,535 | $442,922 |